Navamedic ASA: Invitation to 2024 3rd quarter presentation Publisert: 28.10.2024 Navamedic wins joint Nordic antibiotics tender Publisert: 07.10.2024 Navamedic announces an exclusive agreement with Alex Therapeutics for the development of a Companion App to aid in the treatment of Parkinson’s Disease Publisert: 12.09.2024 Navamedic ASA – Mandatory notification of trade by primary insider Publisert: 09.09.2024 NAVAMEDIC ASA: RESOLUTION TO INCREASE THE SHARE CAPITAL IN CONNECTION WITH EXERCISE OF EMPLOYEE OPTIONS Publisert: 09.09.2024 Navamedic Q2 and H1 2024: Stable growth continues and is supported by a new licensing and supply agreement Publisert: 16.08.2024 FørsteForrige12345NesteSiste
Navamedic announces an exclusive agreement with Alex Therapeutics for the development of a Companion App to aid in the treatment of Parkinson’s Disease Publisert: 12.09.2024
NAVAMEDIC ASA: RESOLUTION TO INCREASE THE SHARE CAPITAL IN CONNECTION WITH EXERCISE OF EMPLOYEE OPTIONS Publisert: 09.09.2024
Navamedic Q2 and H1 2024: Stable growth continues and is supported by a new licensing and supply agreement Publisert: 16.08.2024
